Baihui Li
Key Laboratory Of Cancer Immunology And Biotherapy, State Key Laboratory Of Druggability Evaluation And Systematic Translational Medicine
Tianjin, 300060, China
Tianjin, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
USP18-stabilized ELF3 drives glycolysis and malignant progression in lung adenocarcinoma.
Journal: Acta biochimica et biophysica Sinica
Published: May 29, 2026
RanBP2 promotes ferroptosis resistance and compromises therapeutic response by stabilizing SLC7A1 through LRSAM1 SUMOylation and ubiquitination in lung adenocarcinoma.
Journal: Cell death and differentiation
Published: September 02, 2025
scRNA-seq reveals that VEGF signaling mediates the response to neoadjuvant anlotinib combined with PD-1 blockade therapy in non-small cell lung cancer.
Journal: Journal of translational medicine
Published: January 11, 2025
Risk Prediction of Myelosuppression Following First-line Chemotherapy in Colorectal Cancer.
Journal: Journal of Cancer
Published: September 29, 2024
Integrated machine learning developed a prognosis-related gene signature to predict prognosis in oesophageal squamous cell carcinoma.
Journal: Journal of cellular and molecular medicine
Published: June 14, 2024
Evaluating the relationship between standing height, body mass index, body fat percentage with risk of inguinal hernia: a Mendelian randomization study.
Journal: Scientific reports
Published: March 03, 2024
Siglec-15 on macrophages suppress the immune microenvironment in patients with PD-L1 negative non-metastasis lung adenocarcinoma.
Journal: Cancer gene therapy
Published: September 17, 2023
Non-spatial and spatial heterogeneity revealed a suppressive immune feature of Siglec-15 in lung adenocarcinomas.
Journal: Journal of translational medicine
Published: July 02, 2023
Liquid-liquid phase separation of immiscible polymers at double emulsion interfaces for configurable microcapsules.
Journal: Journal of colloid and interface science
Published: November 10, 2022
CD4+ T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer.
Journal: Cell death & disease
Published: January 22, 2022
Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy.
Journal: Cancer biology & medicine
Published: August 27, 2021
Somatic copy number alteration predicts clinical benefit of lung adenocarcinoma patients treated with cytokine-induced killer plus chemotherapy.
Journal: Cancer gene therapy
Published: July 08, 2021
Last Updated: 09/26/2026